Lens epithelium-derived growth factor is an Hsp70-2 regulated guardian of lysosomal stability in human cancer

Mads Daugaard1, Thomas Kirkegaard-Sørensen, Marie Stampe Ostenfeld

  • 1Apoptosis Department, Danish Centre for Translational Breast Cancer Research, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark.

Cancer Research
|March 17, 2007
PubMed

Insights

Heat shock protein 70-2 (Hsp70-2) depletion causes cancer cell death by damaging lysosomes. Lens epithelium-derived growth factor (LEDGF) protects lysosomes, promoting cancer growth and resistance to cell death.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Heat shock protein 70-2 (Hsp70-2) is crucial for spermatocyte and cancer cell proliferation.
  • Lysosomal membrane permeabilization is a key event in certain cell death pathways.

Purpose of the Study:

  • To investigate the role of Hsp70-2 in cell death pathways.
  • To identify novel regulators of lysosomal stability in human cancer.
  • To explore the oncogenic potential of lens epithelium-derived growth factor (LEDGF).

Main Methods:

  • Hsp70-2 and LEDGF knockdown in cancer cells.
  • Assessment of lysosomal membrane integrity and cell death.
  • Analysis of cell death pathways (caspase-dependent/independent, Bcl-2 sensitivity).
  • In vivo tumorigenicity assays in immunodeficient mice.
  • Correlation analysis of protein expression in human carcinomas.

Main Results:

  • Hsp70-2 depletion induces lysosomal membrane permeabilization and cathepsin-dependent cell death.
  • LEDGF acts as an Hsp70-2-regulated stabilizer of lysosomal membranes in cancer.
  • LEDGF knockdown destabilizes lysosomes, leading to caspase-independent, Bcl-2-resistant cell death.
  • Ectopic LEDGF enhances cancer cell tumorigenicity and protects against cytotoxic agents targeting lysosomes.
  • Increased LEDGF expression correlates with Hsp70-2 in human breast and bladder cancers.

Conclusions:

  • LEDGF is an oncogenic protein that governs a caspase-independent lysosomal cell death pathway.
  • Targeting the LEDGF-lysosomal axis may offer new therapeutic strategies for cancer.
  • Hsp70-2 and LEDGF play critical roles in maintaining cancer cell survival by preserving lysosomal integrity.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...